Navigation Links
Development and clinical approval of biodegradeble magnesium alloy

This biodegradable and bioabsorbable metal decomposes from 6 months to 2 years after being transplanted into human body and hence, medical devices made with these materials are expected to reshape the landscape in the field of fracture treatment, as it reminders second operation to take out the device after patient recovery obsolete. KIST Consortium Consortium participated by U & I (Co.), ASAN Medical Center and Seoul National University (led by Dr. Seok, Hyun-kwang of KIST Biomedical Research Institute) succeeded in developing high strength/low biodegradable metal made from basic elements and minerals essential to human body. The Consortium also developed biodegradable and bioabsorbable medical devices for use in orthopedics & plastic surgery while earning approval to clinically test the device. The clinical trial is currently in progress conducted by Ajou University Medical Center. The heart of the research is matching potentials between the matrix structure of metal and the secondary agents on the matrix structure to overcome the fundamental limitation of metal materials, which is speedy degradation. Using this application, new innovative materials can be developed such as metal alloy with the 2nd and 3rd additional elements while still maintaining the electrochemical nature of pure metal. The remarkable achievement was made possible thanks to the Computational Materials Science Laboratory at Kookmin University (led by Professor Cha Phil-ryung), which helped to create the effects of synergy between computer simulation and technology. With extensive support of the Seoul Strategic Industry Initiative, the key support program of the Seoul City government for Smaller enterprises' R&D, KIST Consortium has succeeded in developing new degradable metal materials inside human body after transplant, and also received approval to clinically test these metals from the Korea Ministry of Food and Drug Safety as a bioabsorbable fixation device to be used in orthopedics and plastic surgery. KIST was selected as a beneficiary for the Seoul Strategic Industry Support Initiative in 2010 and has been working on the project for 3 years. Further, these findings were published in the 2013 August edition of Scientific Report, a sister magazine of the world-renowned scientific journal, Nature.


Contact: Dr. Hyunkwang Seok
Korea Institute of Science and Technology

Related biology news :

1. Regenerative Sustainable Development of Universities and Cities
2. Fast-mutating DNA sequences shape early development; guided evolution of uniquely human traits
3. Exercise during pregnancy gives newborn brain development a head start
4. Allen Institute for Brain Science partners with imec for development of next-generation tools
5. Brain may play key role in blood sugar metabolism and development of diabetes
6. As world sets new development goals, Malaysia calls for poverty relief within green agenda
7. NIH funds development of novel robots to assist people with disabilities, aid doctors
8. EUREKA grant to fund development of new optogenetic technique for mapping neural networks at UMMS
9. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
10. Frontiers launches a new open-access journal in Cell and Developmental Biology
11. Oncogenic signatures mapped in TCGA a guide for the development of personalized therapy
Post Your Comments:
Related Image:
Development and clinical approval of biodegradeble magnesium alloy
(Date:10/8/2015)... , October 8, 2015 ... or the "Company"), a biometric authentication company focused ... of the Wocket® smart wallet announces that revenues ... were approximately $410,000 compared with $113,00 for the ... the 9 months ended September 30, 2015 were ...
(Date:10/7/2015)... -- NXTD ) ("NXT-ID" or the "Company"), ... commerce market and creator of the Wocket® smart wallet ... term executive at American Express has been appointed to ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... the Wocket® smart wallet announces Mr. Stanley E. ...
(Date:10/6/2015)... Oct. 6, 2015  Maverix Biomics, Inc., a ... to its software portfolio with the debut of ... differential expression in eukaryotes. The software is integrated ... cloud-based genomic analysis solution that leverages proven open-source ... next-generation sequencing efforts. Garry Nolan,s ...
Breaking Biology News(10 mins):
(Date:10/12/2015)... SAN FRANCISCO , October 12, 2015 ... reach USD 6.49 billion by 2022, according to a new ... can be attributed to rise in incidence of oncology diseases ... detection market is expected to reach USD 6.49 billion ... Research, Inc. This growth in demand can be attributed to ...
(Date:10/12/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... commercializing novel treatments in oncology, endocrinology and women,s health, ... the Company,s former Senior Vice President, Chief Financial Officer, ... City office.  David A. ... the Company commented, "After a comprehensive review, the Company,s ...
(Date:10/12/2015)... , October 12, 2015 ... Dario™ Diabetes Management Solution, today announced its Medical Director, ... case study at MobiHealth,s 5th EAI International Conference ... "Transforming healthcare through innovations in mobile and wireless technologies," ... England from October 14 - 16, 2015. ...
(Date:10/12/2015)... Belgium , Oct. 12, 2015 VolitionRx ... from a completed clinical study of its NuQ ® ... in the online issue of Clinical Epigenetics , the ... was conducted in collaboration with Lund ... Roland Andersson , MD, PhD, Professor of Surgery and Vice-Dean, ...
Breaking Biology Technology: